刘新民,王墨扬

• 1:中国医师协会心血管内科医师分会结构性心脏病学组
• 2:亚太结构性心脏病俱乐部
• 3:首都医科大学附属北京安贞医院
• 4:中国医学科学院阜外医院

摘要(Abstract)：

经导管主动脉瓣置换术（TAVR）已经日臻成熟，2017—2023年期间我国开展中心数量由不到10家增加至600余家，每年置入量由数百例增加至超过10 000例，TAVR在我国已进入持续稳定发展阶段。《中国经导管主动脉瓣置换术临床路径专家共识》2018版及2021版在我国TAVR快速发展的黄金时期发挥了重要指导作用。随着TAVR领域在循证证据、应用经验、指南更新、器械研发、术式改良等方面的进展，尤其是中国原创技术及治疗方案优化等方面陆续取得重要突破，特更新旧版临床路径专家共识。新版临床路径专家共识对TAVR患者术前临床评价、围术期影像学评估、规范化手术流程、围术期综合管理及术后康复随访等方面进行了详尽阐述，以进一步助力我国TAVR技术健康、规范发展，促进围绕该技术的临床和研究能力的稳定提升。

关键词(KeyWords)： 经导管主动脉瓣置换术;临床评估;影像学评估;规范化手术流程;围术期管理

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划项目（2020YFC2008100）;; 首都临床特色诊疗技术研究及转化应用项目（Z221100007422117）

作者(Author): 刘新民,王墨扬

参考文献(References)：

• [1]中华医学会心血管病学分会结构性心脏病学组，中国医师协会心血管内科医师分会结构性心脏病专业委员会.中国经导管主动脉瓣置换术临床路径专家共识[J].中国介入心脏病学杂志，2018, 26(12):661-668.DOI:10.3969/j. issn. 1004-8812. 2018. 12. 001.
• [2]中国医师协会心血管内科医师分会结构性心脏病专业委员会.中国经导管主动脉瓣置换术临床路径专家共识（2021版）[J].中国介入心脏病学杂志，2022,30(1):7-16.DOI:10.3969/j.issn.1004-8812.2022.01.002.
• [3] Bavaria JE, Tommaso CL, Brindis RG, et al. 2018 AATS/ACC/SCAI/STS expert consensus systems of care document:operator and institutional recommendations and requirements for transcatheter aortic valve replacement:a joint report of the American Association for Thoracic Surgery,American College of Cardiology,Society for Cardiovascular Angiography and Interventions,and Society of Thoracic Surgeons[J]. J Am Coll Cardiol,2019,73(3):340-374. DOI:10.1016/j.jacc.2018.07.002.
• [4]中国医师协会心血管内科医师分会结构性心脏病专业委员会.经导管主动脉瓣置换术中国专家共识（2020更新版）[J].中国介入心脏病学杂志，2020,28(6):301-309. DOI:10.3969/j.issn.1004-8812.2020.06.001.
• [5] Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease:executive summary:a report of the American College of Cardiology/American Heart Association joint Committee on Clinical Practice Guidelines[J]. Circulation,2021,143(5):e35-e71. DOI:10.1161/CIR.0000000000000932.
• [6] Gertz ZM, Pibaro TP, Douglas PS, et al. Implications of left ventricular geometry in low-flow aortic stenosis:a partner 2trial subanalysis[J]. JACC Cardiovascr Imaging, 2019, 12(2):367-368. DOI:10.1016/j.jcmg.2018.10.019.
• [7] Sharma N, Sachedina AK, Kumar S. Low-flow, low-gradient severe aortic stenosis:a review[J]. Heart Int, 2023, 17(1):8-12. DOI:10.17925/HI.2023.17.1.8
• [8]于子凯，许海燕，齐喜玲，等.老年综合评估在经导管主动脉瓣置换术患者心脏康复中的应用价值[J].中华老年心脑血管病杂志，2019, 21(7):691-694. DOI:10.3969/j.issn.1009-0126.2019.07.005.
• [9] Vahanian A,Beyersdorf F,Praz F,et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7):561-632. DOI:10.1093/eurheartj/ehab395.
• [10]中国医师协会心血管内科医师分会结构性心脏病学组，周达新，吴永健.单纯主动脉瓣反流经股动脉主动脉瓣置换中国专家共识2023[J].中国介入心脏病学杂志，2023, 31(11):801-809. DOI:10.3969/j.issn. 1004-8812.2023.11.001.
• [11]中国医师协会放射医师分会心血管学组，国家心血管病专业质控中心心血管影像质控专家工作组，中国研究型医院学会心血管影像专业委员会.经导管主动脉瓣置换术CT检查技术中国专家共识[J].中华放射学杂志，2024, 58(4):365-374. DOI:10.3760/cma.j.cn112149-20231205-00444.
• [12] Blanke P, Weir-Mc Call JR, Achenbach S, et al.C o m p u t e d tomography imaging in the context of transcatheter aortic valve implantation(TAVI)/transcatheter aortic valve replacement(TAVR):an expert consensus document of the Society of Cardiovascular Computed Tomography[J]. JACC Cardiovasc Imaging, 2019, 12(1):1-24. DOI:10.1016/j.jcmg.2018.12.003.
• [13]中国医师协会放射医师分会心血管学组，国家心血管病专业质控中心心血管影像质控专家工作组，中国研究型医院学会心血管影像专业委员会.经导管主动脉瓣置换术CT规范化评估中国专家共识[J].中华放射学杂志，2024,58(6):576-586. DOI:10.3760/cma.j.cn112149-20231214-00470.
• [14] Tarantini G, Tang G, Nai Fovino L, et al. Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery[J]. EuroIntervention, 2023, 19(1):37-52. DOI:10.4244/EIJ-D-22-00958.
• [15] GéNéReux P, Piazza N, Alu MC, et al. Valve academic research consortium 3:updated endpoint definitions FOR aortic valve clinical research[J]. J Am Coll Cardiol, 2021, 77(21):2717-2746. DOI:10.1016/j.jacc.2021.02.038.
• [16] Wang M, Niu G, Chen Y, et al. Development and validation of a deep learning-based fully automated algorithm for preTAVR CT assessment of the aortic valvular complex and detection of anatomical risk factors:a retrospective, multicentre study[J]. EBioMedicine, 2023, 96:104794. DOI:10.1016/j.ebiom.2023.104794.
• [17] Faza N N, Harb S C, Wang DD, et al. Physi ca l a n d computational modeling for transcatheter structural heart interventions[J]. JACC Cardiovas Imaging, 2024, 17(4):428-440. DOI:10.1016/j.jcmg.2024.01.014.
• [18] Haghiashtiani G, Qiu K, Zhingre Sanchez JD, et al. 3D printed patient-specific aortic root models with internal sensors for minimally invasive applications[J]. Sci Adv, 2020, 6(35):eabb4641. DOI:10.1126/sciadv.abb4641.
• [19] Aigner P, Sella Bart E, Panfili S, et al. Quantification of paravalvular leaks associated with TAVI implants using 4D MRI in an aortic root phantom made possible by the use of 3D printing[J]. Front Cardiovasc Med, 2023, 10:1083300. DOI:10.3389/fcvm.2023.1083300.
• [20] Saidy NT, Fernandez-Colino A, Heidari BS, et al. Spatially heterogeneous tubular scaffolds for in situ heart valve tissue engineering using melt electrowriting[J]. Adv Funct Mater,2022, 32:2110716. DOI:10.1002/adfm.202110716.
• [21] Rioux Y, Fradette J, Maciel Y, et al. Biofabrication of sodium alginate hydrogel scaffolds for heart valve tissue engineering[J]. Int J Mol Sci, 2022, 23(15):8567. DOI:10.3390/ijms23158567.
• [22] Yang H, Ji M, Yang M, et al. Fabricating hydrogels to mimic biological tissues of complex shapes and high fatigue resistance[J]. Matter, 2021, 4(6):1-15. DOI:10.1016/j.matt.2021.03.011.
• [23] Reindl M, Lechner I, Holzknecht M, et al. Cardiac m a g n e t i c resonance imaging versus computed tomography to guide transcatheter aortic valve replacement:a randomized, openlabel, noninferiority trial[J]. Circulation, 2023, 148(16):1220-1230. DOI:10.1161/CIRCULATIONAHA.123.066498.
• [24] Sato K, Jones PM. Sedation versus general anesthesia for transcatheter aortic valve replacement[J]. J Thorac Dis, 2018,10(Suppl 30):S3588-S3594. DOI:10.21037/jtd.2018.08.89.
• [25] Hyman MC, Vemulapalli S, Szeto WY, et al. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement:insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy registry[J].Circulation, 2017, 136(22):2132-2140. DOI:10.1161/CIRCULATIONAHA.116.026656.
• [26] Goins AE, Smeltz A, Ramm C, et al. General anesthesia for transcatheter aortic valve replacement:total intravenous anesthesia is associated with less delirium as compared to volatile agent technique[J]. J Cardiothorac Vasc Anesth, 2018, 32(4):1570-1577. DOI:10.1053/j.jvca.2017.12.018.
• [27] Ahmad M, Patel JN, Vipparthy SC, et al. Conscious sedation versus general anesthesia in transcatheter aortic valve replacement:a cost and outcome analysis[J]. Cureus,2019, 11(6):e4812. DOI:10.7759/cureus.4812.
• [28] Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement:vascular outcomes with a fully percutaneous procedure[J]. J Am Coll Cardiol, 2012, 59(2):113-118. DOI:10.1016/j.jacc.2011.08.069.
• [29] Schymik G, Würth A, Bramlage P, et al. Long-term results of transapical versus transfemoral TAVI in a real world population of1000 patients with severe symptomatic aortic stenosis[J]. Circ Cardiovasc Interv, 2014, 8(1):e000761. DOI:10.1161/CIRCINTERVENTIONS.113.000761.
• [30]刘新民，姚晶，董哲，等.使用单动脉入路技术行经导管主动脉瓣置换术三例[J].中国循环杂志，2022, 37(4):421-424. DOI:10.3969/j.issn.1000-3614.2022.04.018.
• [31]刘新民，姚晶，董哲，等.使用单血管入路技术行经导管主动脉瓣置换术1例[J].中华心血管病杂志，2023,51(1):73-75. DOI:10.3760/cma.j.cn112148-20221130-00947.
• [32]姚晶，刘新民，苑飞，等.使用“All in One”单动脉/血管技术行经导管主动脉瓣置换术[J].中华心血管病杂志，2023,51(9):990-994. DOI:10.3760/cma.j.cn112148-20230807-00058.
• [33]宋光远，刘新民，滕思勇，等.使用左心室导丝起搏技术行经导管主动脉瓣置换术[J].中华心血管病杂志，2021, 49(5):461-466. DOI:10.3760/cma.j.cn112148-20210401-00294.
• [34] Lilly SM, Deshmukh AJ, Epstein AE, et al. 2020A C C expert consensus decision pathway on management of conduction disturbances in patients undergoing transcatheter aortic valve replacement:a report of the American College of Cardiology Solution Set Oversight Committee[J]. J Am Coll Cardiol, 2020,76(20):2391-2411. DOI:10.1016/j.jacc.2020.08.050.
• [35] Chang S, Jiang Z, Liu X, et al. Permanent pacemaker reduction using temporary-permanent pacemaker as a 1-month bridge after transcatheter aortic valve replacement:a prospective, multicentre, single-arm, observational study[J]. EClinicalMedicine, 2024, 72:102603. DOI:10.1016/j.eclinm.2024.102603.
• [36] Besis G, Dimitrakakis G, Chetty G, et al. Aortic stenosis presenting with cardiogenic shock. Is there a role for intra-aortic balloon pump use?[J]. Hellenic J Cardiol, 2020, 61(6):447-449. DOI:10.1016/j.hjc.2020.02.004.
• [37] Husser O, Holzamer A, Philipp A, et al. Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation[J]. Catheter Cardiovasc Interv, 2013, 82(4):E542-E551. DOI:10.1002/ccd.24806.
• [38]周政，张龙岩，杨剑，等.急诊经导管主动脉瓣置换术的疗效初探：一项多中心研究[J].中华心血管病杂志，2022,50(7):698-704. DOI:10.3760/cma.j.cn112148-20220601-00434.
• [39] Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement in low-risk patients at five years[J]. N Engl J Med, 2023, 389(21):1949-1960. DOI:10.1056/NEJMoa2307447.
• [40]宋光远，赵跃武，杜国勇，等.股动脉路径经导管主动脉瓣置换术式简化的单中心经验[J].中华心血管病杂志，2022, 50(6):563-569. DOI:10.3760/cma.j.cn112148-20210728-00626.
• [41]赵振燕，张洪亮，张喆，等.在单纯局部麻醉下行经导管主动脉瓣置换术可行性和安全性的初步研究[J].中国循环杂志，2022, 37(4):341-347. DOI:10.3969/j.issn.1000-3614.2022.04.005.
• [42]陈阳，王墨杨，牛冠男，等.中国首例完全局部麻醉且无镇静下极简式经导管主动脉瓣置换术[J].中国循环杂志，2021, 36(10):1027-1030. DOI:10.3969/j.issn.1000-3614.2021.10.014.
• [43] Yao J, Lu ZN, Modine T, et al. Evaluation of the safety and efficacy of a novel anatomical classification and dual anchoring theory to optimize the TAVR strategy for pure severe aortic regurgitation(aurora):a prospective cohort study[J]. BMC Cardiovasc Disord, 2022, 22(1):445. DOI:10.1186/s12872-022-02883-4.
• [44] Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aorticvalve replacement with a self-expanding valve in low-risk patients[J]. N Engl J Med, 2019, 380(18):1706-1715. DOI:10.1056/NEJMoa1816885.
• [45] Sankaramangalam K, Banerjee K, Kandregula K, et al.Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement:a metaanalysis[J]. J Am Heart Assoc, 2017,6(10):1-19.DOI:10.1161/JAHA.117.006092.
• [46] D'ascenzo F, Verardi R, Visconti M, et al. Independent impact of extent of coronary artery disease and percutaneous revascularisation on 30-day and one-year mortality after TAVI:a meta-analysis of adjusted observational results[J].EuroIntervention, 2018, 14(11):e1169-e1177. DOI:10.4244/EIJ-D-18-00098.
• [47] Minten L, Wissels P, Mccutcheon K, et al. The effect of coronary lesion complexity and preprocedural revascularization on 5-year outcomes after TAVR[J]. JACC Cardiovasc Interv, 2022, 15(16):1611-1620. DOI:10.1016/j.jcin.2022.06.019.
• [48] Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement:JACC state-ofthe-art review[J]. J Am Coll Cardiol, 2019, 74(3):362-372. DOI:10.1016/j.jacc.2019.06.012.
• [49]王宇彬，宋光远，张海彤，等.经导管主动脉瓣置换术后心房颤动行左心耳封堵术二例[J].中国循环杂志，2019, 34(2):196-197. DOI:10.3969/j.issn.1000-3614.2019.02.017.
• [50]王宇彬，吴永健，宋光远，等.接受其他心脏介入手术治疗的心房纤颤患者左心耳封堵术应用观察[J].山东医药，2018,58(35):28-32. DOI:10.3969/j.issn.1002-266X.2018.35.007.
• [51] Kapadia SR, Krishnaswamy A, Whisenant B, et a l. Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation[J]. Circulation, 2024, 149(10):734-743. DOI:10.1161/CIRCULATIONAHA.123.067312.
• [52] Price MJ, Friedman DJ, Du C, et al. Comparative safety of transcatheter laao with the first-generation watchman and nextgeneration watchman FLX devices[J]. JACC Cardiovasc Interv, 2022, 15(21):2115-2123. DOI:10.1016/j.jcin.2022.09.002.
• [53] De Backer O, Landes U, Fuchs A, et al. Coronary access after TAVRin-TAVR as evaluated by multidetector computed tomography[J]. JACC Cardiovasc Interv, 2020, 13(21):2528-2538. DOI:10.1016/j.jcin.2020.06.016.
• [54] Akodad M, Sellers S, Landes U, et al. Balloon-expandable valve for treatment of evolut valve failure:implications on neoskirt height and leaflet overhang[J]. JACC Cardiovasc Interv, 2022, 15(4):368-377. DOI:10.1016/j.jcin.2021.12.021.
• [55] Khan JM, Bruce CG, Babaliaros VC, et al. TAVR roulette:caution regarding basilica laceration for TAVR-in-TAVR[J].JACC Cardiovasc Interv, 2020, 13(6):787-789. DOI:10.1016/j.jcin.2019.10.010.
• [56]中华医学会外科学分会.外科病人围手术期液体治疗专家共识（2015）[J].中国实用外科杂志，2015, 35(9):960-966. DOI:10.7504/CJPS.ISSN1005-2208.2015.09.14.
• [57] Ten Berg J, Sibbing D, Rocca B, et al. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation:a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions(EAPCI), in collaboration with the ESC Council on Valvular Heart Disease[J]. Eur Heart J, 2021, 42(23):2265-2269. DOI:10.1093/eurheartj/ehab196.
• [58]中华医学会心血管病学分会，中华心血管病杂志编辑委员会.经导管主动脉瓣植入术后抗血栓治疗中国专家共识[J].中华心血管病杂志，2022,50(2):117-131. 10.3760/cma.j.cn112148-20210721-00608.
• [59] Hu X, Xu H, Wang C, et al. Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement:protocol for a multicentre, open-label, randomised controlled clinical trial[J]. BMJ Open, 2023, 13(11):e076781. DOI:10.1136/bmjopen-2023-076781.
• [60]中国医师协会心血管内科医师分会结构性心脏病专业委员会.经导管主动脉瓣置换术后运动康复专家共识[J].中国介入心脏病学杂志，2020, 28(7):361-368. DOI:10.3969/j. issn. 1004-8812. 2020. 07. 001.